Beijing Tongren Hospital, Capital Medical University
Beijing Tongren Hospital, Capital Medical University
Beijing, China15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Screening for Hyperopic Reserve in Kindergarten | eye disorder, myopia, refractive error | Recruiting | Not stated | 2026-10-01 | NCT07851532 | |
| The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens | eye disorder, myopia, refractive error | Active, not recruiting | Not applicable | 2026-09-18 | NCT05886348 | |
| Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Recruiting | Phase 3 | 2026-09-09 | NCT07711262 | |
| A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, relapsed/refractory diffuse large B-cell lymphoma | Recruiting | Phase 3 | 2026-07-20 | NCT07409428 | |
| A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Active, not recruiting | Phase 3 | 2026-05-15 | NCT06666855 | |
| A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) in China | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 3 | 2026-05-05 | NCT07226752 | |
| A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Phase 2 / Phase 3 | 2026-05-05 | NCT06413654 | |
| Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations | Inherited Retinal Dystrophy Associated With RPE65 Mutations | Active, not recruiting | Phase 1 | 2026-03-06 | NCT06196827 | |
| A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps | Chronic Rhinosinusitis With Nasal Polyps | Active, not recruiting | Phase 3 | 2026-03-03 | NCT06516302 | |
| Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Recruiting | Phase 2 | 2026-03-02 | NCT07441993 | |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-02-03 | NCT05183646 | |
| Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, hypopharyngeal carcinoma, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-12-23 | NCT07248956 | |
| Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma | Extranodal Natural Killer T Cell Lymphoma | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-13 | NCT05464433 | |
| Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) | age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2024-11-27 | NCT05672121 | |
| Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Leber hereditary optic neuropathy, Nutritional and Metabolic Diseases, cranial nerve neuropathy, eye disorder, hereditary disease, hereditary optic atrophy, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, optic atrophy, optic nerve disorder | Recruiting | Phase 2 / Phase 3 | 2022-11-14 | NCT04912843 |